Myasthenia gravis
Neurology · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
An autoimmune disorder of the neuromuscular junction causing fatigable weakness, typically ocular and bulbar. The priority is to recognise and protect against myasthenic crisis (respiratory failure) and to treat with symptomatic and immunosuppressive therapy. First action: assess bulbar and respiratory function (FVC), and send acetylcholine-receptor antibodies.
Red flags
- Refer all suspected cases to neurology
- Admit for bulbar dysfunction or falling/forced vital capacity — a myasthenic crisis needs HDU/ITU, IVIg or plasma exchange and early airway support
- Don't rely on oxygen saturations alone; trend the FVC
Assessment
Investigations
- Anti-AChR antibodies (anti-MuSK if negative)
- Repetitive nerve stimulation/single-fibre EMG
- CT/MRI thorax for thymoma
- Bedside tests of fatigability; serial FVC/NIF to monitor respiratory reserve
- TFTs and screen for associated autoimmunity
Management
- Symptomatic: pyridostigmine (acetylcholinesterase inhibitor)
- Immunosuppression: corticosteroids (start low/titrate to avoid initial worsening) plus steroid-sparing agents (azathioprine, mycophenolate); rituximab for refractory/anti-MuSK disease; newer complement/FcRn therapies in selected cases
- Thymectomy for thymoma and selected AChR-positive patients
- Crisis: IV immunoglobulin or plasma exchange plus airway/ventilatory support
- Avoid known precipitant drugs
Disposition
Refer all suspected cases to neurology.
Complications & pitfalls
- Myasthenic crisis with respiratory failure and aspiration; treatment side-effects (steroid toxicity, immunosuppression infection); and cholinergic crisis from excess anticholinesterase
Exam pearls
- In myasthenic crisis the oxygen saturation stays normal until the patient suddenly tires and arrests — monitor the forced vital capacity, and intubate on a falling FVC rather than waiting for hypoxia.
- Monitoring & follow-up: Monitor symptoms, FVC and treatment response; immunosuppression safety bloods. Provide a list of drugs to avoid and a crisis plan. Neurology follow-up and, where relevant, post-thymectomy review.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.